KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Non-Current Deffered Revenue (2017 - 2025)

Historic Non-Current Deffered Revenue for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $192000.0.

  • Bionano Genomics' Non-Current Deffered Revenue fell 2699.62% to $192000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $192000.0, marking a year-over-year decrease of 2699.62%. This contributed to the annual value of $267000.0 for FY2024, which is 7337.66% up from last year.
  • Per Bionano Genomics' latest filing, its Non-Current Deffered Revenue stood at $192000.0 for Q3 2025, which was down 2699.62% from $243000.0 recorded in Q2 2025.
  • Bionano Genomics' Non-Current Deffered Revenue's 5-year high stood at $292000.0 during Q1 2025, with a 5-year trough of $108000.0 in Q1 2021.
  • Moreover, its 5-year median value for Non-Current Deffered Revenue was $186000.0 (2023), whereas its average is $188210.5.
  • As far as peak fluctuations go, Bionano Genomics' Non-Current Deffered Revenue soared by 15357.14% in 2021, and later crashed by 2886.6% in 2024.
  • Over the past 5 years, Bionano Genomics' Non-Current Deffered Revenue (Quarter) stood at $146000.0 in 2021, then dropped by 13.01% to $127000.0 in 2022, then increased by 21.26% to $154000.0 in 2023, then soared by 73.38% to $267000.0 in 2024, then dropped by 28.09% to $192000.0 in 2025.
  • Its Non-Current Deffered Revenue stands at $192000.0 for Q3 2025, versus $243000.0 for Q2 2025 and $292000.0 for Q1 2025.